Specificities of the methodology of survival analysis in dialysis patients;Spécificités méthodologiques de l'analyse de survie des patients dialysés

Nephrologie et Therapeutique

Volumn 4, Issue 7, 2008, Pages 553-561

  Villar, Emmanuel ^a   Frimat, Luc ^b   Ecochard, René ^c   Labeeuw, Michel ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b CHU NANCY BRABOIS   (France)

^c LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

Author keywords

Cox; End stage renal disease; Epidemiology; Kaplan Meier; Standardised mortality ratio; Survival

Indexed keywords

DEATH; HEMODIALYSIS PATIENT; HUMAN; KAPLAN MEIER METHOD; KIDNEY FAILURE; MORTALITY; PROPORTIONAL HAZARDS MODEL; RISK; RISK FACTOR; SHORT SURVEY; SURVIVAL;

COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY FAILURE, CHRONIC; PROBABILITY; REGRESSION ANALYSIS; RENAL DIALYSIS; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 57049164311     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2008.02.008     Document Type: Short Survey

References (42)

1. Frimat L. Apports de l'épidémiologie clinique à la néphrologie basée sur les preuves. Nephrologie 22 (2001) 199-203
2. ERA-EDTA Registry: ERA-EDTA Registry 2005 Annual Report. Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands, June 2007.
3. USRDS 2006 Annual Data Report. Atlas of end-stage renal disease in the United States. National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA, 2006.
4. ANZDATA Registry Report 2006. Australia and New Zealand Dialysis and Transplant Registry. Adelaide, Australia, 2006.
5. Couchoud C., Stengel B., Jacquelinet C., and Reseau d'Épidemiologie et d'Information en Nephrologie et Agence de la Biomedecine. Rapport Annuel REIN 2005. Nephrol Ther 3 Suppl. 1 (2007) S1-S82
6. Couchoud C., Stengel B., Landais P., Aldigier J.C., de Cornelissen F., Dabot F., et al. The renal epidemiology and information network (REIN): a new registry for end-stage renal disease. Nephrol Dial Transplant 21 (2006) 411-418
7. ème congrès international d'actuaires. Amsterdam 1912;2:327-43.
8. Kaplan E.L., and Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
9. Rothman K.J. Estimation of confidence limits for the cumulative probability of survival probability of survival in life table analysis. J Chron Dis 31 (1978) 557-560
10. Fleming T.R., and Harrington D.P. Counting processes and survival analysis (1991), John Wiley and Sons, Inc, New York
11. Jager K.J., Stel V.S., Wanner C., Zoccali C., and Dekker F.W. The valuable contribution of observational studies to nephrology. Kidney Int 72 (2007) 671-675
12. Cox D.R. Regression model and life tables (with discussion). J Roy Stat Soc B34 (1972) 187-220
13. Therneau T.M., and Grambsch P.M. Modeling survival data. Extending the Cox model. Statistics for biology and health (2000), Springer Ed. Mayo Foundation, New York
14. Schoenfeld D.A., and Richret D.J. Nomograms for calculating the numbers of patients needed for a clinical trial with survival as an endpoint. Biometrics 38 (1982) 163-170
15. Villar E., Boissonnat P., Sebbag L., Hendawy A., Cahen R., Trolliet P., et al. Poor outcome in heart transplant patients with end-stage renal failure. Nephrol Dial Transplant 22 (2007) 1383-1389
16. van Dijk P.C., Jager K.J., Stengel B., Gronhagen-Riska C., Feest T.G., and Briggs J.D. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe. Kidney Int 67 (2005) 1489-1499
17. van Wijk I., Kapelle L.J., van Gijn J., Koudstaal P.J., Francke C.L., Vermeulen M., et al., LiLAC Study group. Long-term survival and vasculare event risk after transient ischaemic attack or minor ischeamic stroke: a cohort study. Lancet 365 (2005) 2098-2104
18. Korn E.L., Graubard B.I., and Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of time-scale. Am J Epidemiol 145 (1997) 72-80
19. Pencina M.J., Larson M.G., and D'Agostino R.B. Choice of time scale and its effect on significance of predictors in longitudinal studies. Stat Med 26 (2007) 1343-1359
20. Villar E., Remontet L., Labeeuw M., Ecochard R., and on behalf of the Association Regionale de Nephrologues de Rhone-Alpes and the French Renal and Information Network (REIN) Registry. Effects of age, sex and diabetes on excess death in end-stage renal failure. J Am Soc Nephrol 18 (2007) 2125-2134
21. Breslow NE, Day NA. Statistical methods in cancer research. The design and analysis of cohort study vol. 2. Lyon, France: International Agency for Research on Cancer; 1987, p. 65-99. [Scientific publication 82].
22. www.insee.fr.
23. Rosenbaum PR. Observational studies, 2nd Ed. Springer series in statistics, New York: Springer-Verlag Ed.; 2002.
24. Giorgi R., Abrahamowicz M., Quantin C., Bolard P., Estève J., Gouvernet J., et al. A relative survival regression model using B-spline function to model non-proportional hazards. Stat Med 22 (2003) 2767-2784
25. Remontet L., Bossard N., Belot A., Estève J., and The French network of cancer registries (FRANCIM). An overall strategy based on regression models to estimate relative survival and model the effects of prognostic factors in cancer survival studies. Stat Med 26 (2007) 2214-2228
26. Vonesh E.F., Snyder J.J., Foley R.N., and Collins A.J. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us?. Kidney Int suppl. 103 (2006) s3-s11
27. Frimat L., Durand P.Y., Loos-Ayav C., Villar E., Panescu V., Brincon S., et al. Impact of first dialysis modality on outcome of patients contraindicated for kidney transplant. Perit Dial Int 26 (2006) 231-239
28. McDonald S.P., and Russ G.R. Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New-Zealand, 1991-2001. Nephrol Dial Transplant 17 (2002) 2212-2219
29. Wolfe R., Ashby W., Milford E., Ojo A.O., Ettenger R.E., Agodoa L.Y., et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Eng J Med 341 (1999) 1725-1730
30. Villar E., Chang S.H., and McDonald S.P. Incidences, treatments, outcomes, and gender effect on survival in end-stage renal disease patients by diabetic status in Australia and New Zealand (1995-2005). Diabetes Care 30 (2007) 3070-3076
31. van Manen J.G., van Dijk P.C., Stel V.S., Dekker F.W., Clèries M., Conte F., et al. Confounding effect of comorbidity on survival studies in patients on renal replacement therapy. Nephrol Dial Transplant 22 (2007) 187-195
32. Eknoyan G., Beck G.J., Cheung A.K., Daugirdas J.T., Greene T., Kusek J.W., et al., HEMO Study group. N Engl J Med 347 (2002) 2010-2019
33. Wanner C., Krane V., März W., Olchewski M., Mann J.F., Ruf G., et al., German diabetes and dialysis study investigator. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 (2005) 238-248
34. Zannad F., Kessler M., Lehert P., Grünfeld J.P., Thuilliez C., Leizorovicz A., et al. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future study. Kidney Int 70 (2006) 1318-1324
35. Cano N.J., Fouque D., Roth H., Aparicio M., Azar R., Canaud B., et al., the French Study Group for Nutrition in Dialysis. Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. J Am Soc Nephrol 18 (2007) 2583-2591
36. Goovaerts T., Jadoul M., and Goffin E. Influence of a pre-dialysis education program (PDEP) on the mode of renal replacement therapy. Nephrol Dial Transplant 20 (2005) 1842-1847
37. Korevaar J.C., Feith G.W., Dekker F.W., van Manen J.G., Boeschoten E.W., Bossuyt P.M., et al., NECOSAD Study group. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized control trial. Kidney Int 64 (2003) 2222-2228
38. Zoccali C., and Mallamaci F. Adiponectin and renal disease progression: another epidemiologic conundrum?. Kidney Int 71 (2007) 1195-1197
39. Ware J.H. The limitations as risk factors as prognosis tolls. New Engl J Med 355 (2006) 2615-2617
40. Hill A.B. The environment and disease: association or causation?. Proc R Soc Med 58 (1965) 295-300
41. Couchoud C., Moranne O., Frimat L., Labeeuw M., Allot V., and Stengel B. Associations between comorbidities, treatment choice and outcome in the elderly with end-stage renal disease. Nephrol Dial Transplant 22 (2007) 3246-3254
42. von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., Vandenbroucke J.P., and STROBE initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studied. Ann Int Med 147 (2007) 573-577